3-[3-(4-METHYLPHENYL)-2,1-BENZISOXAZOL-5-YL]ACRYLIC ACID
![3-[3-(4-METHYLPHENYL)-2,1-BENZISOXAZOL-5-YL]ACRYLIC ACID price.](/StructureFile/ChemBookStructure3/GIF/CB0240303.gif)
|
- $721 - $2088
- Product name: 3-[3-(4-METHYLPHENYL)-2,1-BENZISOXAZOL-5-YL]ACRYLIC ACID
- CAS: 344276-77-3
- MF: C17H13NO3
- MW: 279.29
- EINECS:
- MDL Number:MFCD00663847
- Synonyms:3-[3-(4-METHYLPHENYL)-2,1-BENZISOXAZOL-5-YL]ACRYLIC ACID;(2E)-3-[3-(4-methylphenyl)-2,1-benzoxazol-5-yl]prop-2-enoic acid;2-Propenoic acid, 3-[3-(4-methylphenyl)-2,1-benzisoxazol-5-yl]-
3 prices
Selected condition：
Brand
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerMatrix Scientific
- Product number045272
- Product description3-[3-(4-Methylphenyl)-2,1-benzisoxazol-5-yl]-acrylic acid >95%
- Packaging500mg
- Price$721
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number045272
- Product description3-[3-(4-Methylphenyl)-2,1-benzisoxazol-5-yl]-acrylic acid >95%
- Packaging1g
- Price$910
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number045272
- Product description3-[3-(4-Methylphenyl)-2,1-benzisoxazol-5-yl]-acrylic acid >95%
- Packaging5g
- Price$2088
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Matrix Scientific | 045272 | 3-[3-(4-Methylphenyl)-2,1-benzisoxazol-5-yl]-acrylic acid >95% | 500mg | $721 | 2021-12-16 | Buy |
| Matrix Scientific | 045272 | 3-[3-(4-Methylphenyl)-2,1-benzisoxazol-5-yl]-acrylic acid >95% | 1g | $910 | 2021-12-16 | Buy |
| Matrix Scientific | 045272 | 3-[3-(4-Methylphenyl)-2,1-benzisoxazol-5-yl]-acrylic acid >95% | 5g | $2088 | 2021-12-16 | Buy |
Properties
Melting point :295°
Boiling point :295°C
Density :1.288±0.06 g/cm3(Predicted)
pka :4.09±0.50(Predicted)
Boiling point :295°C
Density :1.288±0.06 g/cm3(Predicted)
pka :4.09±0.50(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|